Latest Breaking News On - Christopher drake - Page 1 : comparemela.com

KP1077 Demonstrates Safety in Idiopathic Hypersomnia Patients

The phase 2 trial explored the safety and efficacy of KP1077 in reducing daytime sleepiness and sleep inertia.

Christopher drakeZevra therapeutics incZevra therapeuticsEpworth sleepiness scaleTherapeutics incAdrian quartelSleep inertia visual analog scaleTrial highlightsBrain fog scaleExcessive daytime sleepiness

Johnson Leads The Final 21 Players of Day 1b; Fouts, Barrientos, and Lafata Bag

Johnson Leads The Final 21 Players of Day 1b; Fouts, Barrientos, and Lafata Bag
pokernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pokernews.com Daily Mail and Mail on Sunday newspapers.

Christopher drakeAndre allenKeith heineWilliam mccrackenCasey henryMichael foutsJustin dreilingMark lafataCory smithPhilip boydMark barrientosKameron johnsonTed forsheyDaniel donk hughesMichael lucasPhillip tindell

The Final Winner of The Season Will Be Crowned Today In The RGPS Kansas City Main Event

The Final Winner of The Season Will Be Crowned Today In The RGPS Kansas City Main Event
pokernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pokernews.com Daily Mail and Mail on Sunday newspapers.

United statesKameron johnsonCory smithJesse jonesMichael millerWalker miskellyChris audrainMichael foutsMark barrientosForrest kollarGannon ryan ramsdellJackson turrentineKeith murrellMark lafataJeff grimesSteven mckuin

KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms

A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.

United statesChristopher drakeHenry ford health christopher drakeAmerican academy of sleep medicineDrug administrationUs drug enforcement agencyHenry ford healthZevra therapeuticsAmerican academyOrphan drug designationEnforcement agencyEpworth sleepiness scaleIdiopathic hypersomnia severity scaleSleep inertia visual analog scaleEpworth sleepinessBrain fog severity scale

Zevra Reports Positive Phase 2 Results for IH Drug Candidate

Zevra Therapeutics announced positive topline results from its phase 2 clinical trial evaluating KP1077 for idiopathic hypersomnia (IH).

Putilich dreamstimeChristopher drakeNeil mcfarlaneDrug administrationZevra therapeuticsEpworth sleepiness scaleIdiopathic hypersomnia severity scaleSleep inertia visual analog scaleBrain fog